FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055366449> ?p ?o ?g. }

• W2055366449 endingPage "2" @default.
• W2055366449 startingPage "1" @default.
• W2055366449 abstract "Lung Cancer ManagementVol. 1, No. 1 ForewordFree AccessThe new language of lung cancerDavid J SugarbakerDavid J SugarbakerEditor-in-Chief; Division of Thoracic Surgery, Brigham & Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA. Search for more papers by this authorEmail the corresponding author at dsugarbaker@partners.orgPublished Online:1 Jun 2012https://doi.org/10.2217/lmt.12.9AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail Lung cancer management is an ever-evolving paradigm with a prescient need for cutting-edge communication to satisfy both clinicians and basic scientists. The scientific journal is a forum for communicating data and ideas. The technical nature of this information demands a unique and precise language. For many decades, these concepts have been presented in journals designed to reach narrowly defined audiences (i.e., clinical vs basic science, medicine vs surgery or generalist vs specialist). This environment fostered the proliferation of numerous highly specialized journals, each serving a homogeneous readership. While the trend toward specialization is unlikely to change, the composition of the audience has been appreciably altered by the dawning of the digital age and the advent of individualized patient care.Fueled by advances in molecular biology and computer science, personalized medicine mandates the integration of new knowledge, new therapies and new paradigms. Therefore, journals must adapt. Their structure and content must promote the integration of new information and a common understanding among individuals with diverse backgrounds and technical skills (e.g., physician, surgeon, clinician, researcher, computer scientist, software engineer, molecular biologist and mathematician, among many others). Delivering on the promise of individualized care not only demands a new partnership between basic and clinical science, but also more support for translational research leading to innovative personalized therapies. Following on from the dawn of this new era, Lung Cancer Management is specifically designed to serve this trend.Depending on your perspective, you may view this story as the rise of the clinician’s role in bench-to-bedside medicine, while others may champion the basic scientist’s role. In reality, the integration of personalized care is a 50/50 partnership between basic and clinical science. Each of the partners has to understand the language of the other. The language of the discipline must, too, evolve. Highly specialized techniques cannot be fully and successfully implemented without a meeting of the minds. It is communication, specifically the integration of specialist knowledge, that takes center stage in the drive for innovation in lung cancer research and treatment.Nowhere is the complexity of cancer more poignantly clear than in the management of lung cancer. Over the past decade, we have become increasingly aware that cancers in general, and lung cancer in particular, have a complex biology and cannot be treated with a ‘one-size-fits-all’ approach. To avail our patients of new life-extending therapies, it is critical for all partners to actively engage in this comprehensive conversation. This journal aspires to invite everyone involved in lung cancer management to participate in this important discussion. I am delighted to be associated with the launch of this exciting new multidisciplinary dialog.Financial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.FiguresReferencesRelatedDetails Vol. 1, No. 1 Follow us on social media for the latest updates Metrics Downloaded 323 times History Published online 1 June 2012 Published in print June 2012 Information© Future Medicine LtdFinancial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2055366449 created "2016-06-24" @default.
• W2055366449 creator A5045600892 @default.
• W2055366449 date "2012-06-01" @default.
• W2055366449 modified "2023-09-27" @default.
• W2055366449 title "The new language of lung cancer" @default.
• W2055366449 doi "https://doi.org/10.2217/lmt.12.9" @default.
• W2055366449 hasPublicationYear "2012" @default.
• W2055366449 type Work @default.
• W2055366449 sameAs 2055366449 @default.
• W2055366449 citedByCount "0" @default.
• W2055366449 crossrefType "journal-article" @default.
• W2055366449 hasAuthorship W2055366449A5045600892 @default.
• W2055366449 hasConcept C142724271 @default.
• W2055366449 hasConcept C166957645 @default.
• W2055366449 hasConcept C17744445 @default.
• W2055366449 hasConcept C199539241 @default.
• W2055366449 hasConcept C2776256026 @default.
• W2055366449 hasConcept C2777826127 @default.
• W2055366449 hasConcept C41008148 @default.
• W2055366449 hasConcept C509550671 @default.
• W2055366449 hasConcept C71924100 @default.
• W2055366449 hasConcept C82307848 @default.
• W2055366449 hasConcept C95457728 @default.
• W2055366449 hasConceptScore W2055366449C142724271 @default.
• W2055366449 hasConceptScore W2055366449C166957645 @default.
• W2055366449 hasConceptScore W2055366449C17744445 @default.
• W2055366449 hasConceptScore W2055366449C199539241 @default.
• W2055366449 hasConceptScore W2055366449C2776256026 @default.
• W2055366449 hasConceptScore W2055366449C2777826127 @default.
• W2055366449 hasConceptScore W2055366449C41008148 @default.
• W2055366449 hasConceptScore W2055366449C509550671 @default.
• W2055366449 hasConceptScore W2055366449C71924100 @default.
• W2055366449 hasConceptScore W2055366449C82307848 @default.
• W2055366449 hasConceptScore W2055366449C95457728 @default.
• W2055366449 hasIssue "1" @default.
• W2055366449 hasLocation W20553664491 @default.
• W2055366449 hasOpenAccess W2055366449 @default.
• W2055366449 hasPrimaryLocation W20553664491 @default.
• W2055366449 hasRelatedWork W1967103478 @default.
• W2055366449 hasRelatedWork W2032912323 @default.
• W2055366449 hasRelatedWork W2148097028 @default.
• W2055366449 hasRelatedWork W2372561159 @default.
• W2055366449 hasRelatedWork W2375344515 @default.
• W2055366449 hasRelatedWork W2380382254 @default.
• W2055366449 hasRelatedWork W2390152934 @default.
• W2055366449 hasRelatedWork W2412727163 @default.
• W2055366449 hasRelatedWork W2748952813 @default.
• W2055366449 hasRelatedWork W2899084033 @default.
• W2055366449 hasVolume "1" @default.
• W2055366449 isParatext "false" @default.
• W2055366449 isRetracted "false" @default.
• W2055366449 magId "2055366449" @default.
• W2055366449 workType "article" @default.